Biopharmaceutical Analysis & Statistics, January 2013 (p7)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: protein, biomedical, antibody, more »

181-220 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the ...

  • Industries : Biopharmaceutical
Antibodies in Oncology: Drug Pathway Analyzer 2014

Antibodies in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 608 antibody drugs known to affect more than 206 specific intracellular signaling pathways for the treatment ...

  • Industries : Biopharmaceutical
Sports Nutrition Market Analysis in Taiwan

Sports Nutrition Market Analysis in Taiwan

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

With economic recovery from the second half of 2009, sales of sports nutrition products increased, and in 2010 saw 2% growth in current value terms. Euromonitor International's report offers a comprehensive ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Taiwan
Sanofi SA - Strategy and SWOT Report

Sanofi SA - Strategy and SWOT Report

  • $ 175
  • Company report
  • July 2014
  • by MarketLine

Sanofi SA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate ...

  • Industries : Biopharmaceutical
  • Countries : France
Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review

Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • July 2014
  • by Global Data

Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to ...

  • Industries : Biopharmaceutical
  • Countries : Iceland
Sports Nutrition Market Overview in Brazil

Sports Nutrition Market Overview in Brazil

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Creatine was released by ANVISA (Health Surveillance Agency) to be sold as sport nutrition in May 2010. Prior to that, creatine was classified a medicine by ANVISA and sports nutrition manufacturers had ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Brazil
Vaccine Partnering Terms and Agreements

Vaccine Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • July 2014
  • by Currentpartnering

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Biopharmaceutical
  • Countries : United States
Sports Nutrition Market Analysis in New Zealand

Sports Nutrition Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

This is evident in 2010’s growth of 1%, being lower than the review period CAGR of 4%. Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : New Zealand
Advances in Enzyme Technology for the Food Industry

Advances in Enzyme Technology for the Food Industry

  • $ 240
  • Industry report
  • July 2014
  • by Food Tech. Intelligence

Food Technology Intelligence, Inc. offers a revised and updated in-depth report analyzing several new developments in enzyme research. The report will give you a first-hand look at many commercially-viable ...

  • Industries : Biopharmaceutical, Agriculture
Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2014

5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“5-Lipoxygenase Activating Protein (FLAP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2) -Pipeline Insights, 2014

Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Biopharmaceutical
AMP Activated Protein Kinase (AMPK) Inhibitors -Pipeline Insights, 2014

AMP Activated Protein Kinase (AMPK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“AMP Activated Protein Kinase (AMPK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biopharmaceutical
Amyloid Protein Blockers -Pipeline Insights, 2014

Amyloid Protein Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Amyloid Protein Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Biopharmaceutical
Anti-CD105 Antibody -Pipeline Insights, 2014

Anti-CD105 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD105 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Anti-CD152 Antibody -Pipeline Insights, 2014

Anti-CD152 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD152 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Anti-CD19 Antibody -Pipeline Insights, 2014

Anti-CD19 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD19 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Anti-CD22 Antibody -Pipeline Insights, 2014

Anti-CD22 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD22 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Anti-CD25 Antibody -Pipeline Insights, 2014

Anti-CD25 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD25 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD274 (PD-L1) Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Biopharmaceutical
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014

Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD279 (PD-1) Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Biopharmaceutical
Anti-CD28 Antibody -Pipeline Insights, 2014

Anti-CD28 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD28 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Anti-CD3 Antibody -Pipeline Insights, 2014

Anti-CD3 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD3 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Anti-CD30 Antibody -Pipeline Insights, 2014

Anti-CD30 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD30 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
About 3 200 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry - Company Report, October 2014

  • Department of Health and Human Services
  • October 2014
    12 pages
  • Vaccine  

  • Africa  

    United States  

    Uganda  

View report >

Global Vaccine Industry

September 2014

Vaccine Market In The Us

September 2014

27 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.